Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effect

We investigated the effect of angiotensin receptor neprilysin inhibitor (ARNI) on glycemic control in Korean patients. This retrospective cohort study was conducted at a single tertiary hospital. We compared the HbA(1c) level reduction between the ARNI and angiotensin-converting enzyme inhibitors (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Heungjo, Park, Gyunam, Hahn, Jongsung, Oh, Jaewon, Chang, Min Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188559/
https://www.ncbi.nlm.nih.gov/pubmed/35690600
http://dx.doi.org/10.1038/s41598-022-13366-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188559/
https://www.ncbi.nlm.nih.gov/pubmed/35690600
http://dx.doi.org/10.1038/s41598-022-13366-z

Ejemplares similares